Longevity-CancerDB: unlocking the distinctive features and roles of longevity-associated genes in tumourigenesis

Li Guo; Daoliang Xia; Jiaming Jin; Shizheng Xiong; Xinru Xu; Lulu Luo; Xueni Yang; Xinmiao Zhao; Dekang Ren; Jiafeng Yu; Tingming Liang

doi:10.1002/ctm2.1557

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1557 DOI: 10.1002/ctm2.1557

LETTER TO THE JOURNAL

Longevity-CancerDB: unlocking the distinctive features and roles of longevity-associated genes in tumourigenesis

Author information +

History +

PDF

Cite this article

Download citation ▾

Li Guo, Daoliang Xia, Jiaming Jin, Shizheng Xiong, Xinru Xu, Lulu Luo, Xueni Yang, Xinmiao Zhao, Dekang Ren, Jiafeng Yu, Tingming Liang. Longevity-CancerDB: unlocking the distinctive features and roles of longevity-associated genes in tumourigenesis. Clinical and Translational Medicine, 2024, 14(1): e1557 DOI:10.1002/ctm2.1557

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	de Magalhaes JP, Wuttke D, Wood SH, Plank M, Vora C. Genome-environment interactions that modulate aging: powerful targets for drug discovery. Pharmacol Rev. 2012;64(1):88-101.

[2]	Renault VM, Thekkat PU, Hoang KL, et al. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene. 2011;30(29):3207-3221.

[3]	Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet. 2006;7(6):436-448.

[4]	Horikawa I. Balancing and differentiating p53 activities toward longevity and no cancer? Cancer Res. 2020;80(23):5164-5165.

[5]	Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Erlotinib in cancer treatment. Ann Oncol. 2007;18(6):vi35-vii41.

[6]	Hu W, Zheng S, Guo H, et al. PLAGL2-EGFR-HIF-1/2alpha signaling loop promotes HCC progression and erlotinib insensitivity. Hepatology. 2021;73(2):674-691.

[7]	Guerra E, Alberti S. TP53 gene indels impact on cancer outcomes. J Clin Oncol. 2022:41(1):145-147.

[8]	Holbrook WP, Ogmundsdottir HM. Oral Lichen planus and mutated TP53-A road to cancer? Dent J. 2022;10(9):176.

[9]	Zhu YH, Li JB, Wu RY, et al. Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma. Hepatol Res. 2020;50(1):110-120.

[10]	Le L, Qipeng W, Chunmeng M, et al. 5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression. Eur J Pharmacol. 2023;950:175736.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.